| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.53 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |